Physician
Francemone, Charles
Francemone, Charles was paid $11K by Medicaid between Aug 2020 and Jan 2024, across 5 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 76% of everything it billed.
33Billing provider infoFRANCEMONE, CHARLES
WILLIAMSVILLE, NY 14221
WILLIAMSVILLE, NY 14221
33aNPI1346231693assigned 11/03/2005
33bProvider typePediatrics Physician
28Total paid$11K
24GClaims331
24DCodes billed5
24AFirst – last monthAug 2020 – Jan 2024
Compared with peers
Next to other Pediatrics Physician providers in New York
Rank by total paid#1,079 of 1,983
Median peer was paid$17K
This provider vs. median0.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 46 | $1K | |
| 2021 | 94 | $1K | |
| 2022 | 145 | $5K | |
| 2023 | 29 | $2K | |
| 2024incomplete | 17 | $1K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 76% | 150 | 146 | $8K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 16% | 49 | 49 | $2K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 8.3% | 54 | 54 | $903.84 |
| 99051 | <1% | 14 | 14 | $0.13 | |
| 99072 | 0% | 64 | 62 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.